Approval of the Registration Document

AFFLUENT MEDICAL announces the approval of its Registration Document by the French Financial Markets Authority (Autorité des marchés financiers – AMF) as part of its proposed IPO on the Euronext Paris regulated market

Affluent Medical, a French medtech specialising in the international development and industrial scale-up of innovative medical prostheses, at a clinical stage, to treat urinary incontinence and mitral cardiac insufficiency, announces today the approval of its Registration Document by the AMF under number I.21-007 on 12 April 2021.

The approval of this Registration Document is the first step in Affluent Medical’s proposed IPO on the Euronext Paris regulated market, subject to market conditions and the approval by the AMF of the Prospectus relating to the operation.